Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer. Issue 2 (December 2015) - Cohen, Ezra; Moore, Kathleen; Slomovitz, Brian; Chung, Christine; Anderson, Matthew; Morris, Shannon; Mauro, David; Burtness, Barbara